- Home
- CYTK vs AXS Comparison
CYTK vs AXS Comparison
Compare CYTK & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- AXS
- Stock Information
- Founded
- CYTK 1997
- AXS 2001
- Country
- CYTK United States
- AXS Bermuda
- Employees
- CYTK N/A
- AXS N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- AXS Property-Casualty Insurers
- Sector
- CYTK Health Care
- AXS Finance
- Exchange
- CYTK Nasdaq
- AXS Nasdaq
- Market Cap
- CYTK 6.0B
- AXS 6.7B
- IPO Year
- CYTK 2004
- AXS N/A
- Fundamental
- Price
- CYTK $48.18
- AXS $88.07
- Analyst Decision
- CYTK Buy
- AXS Strong Buy
- Analyst Count
- CYTK 16
- AXS 6
- Target Price
- CYTK $83.67
- AXS $92.17
- AVG Volume (30 Days)
- CYTK 1.2M
- AXS 476.5K
- Earning Date
- CYTK 11-06-2024
- AXS 10-30-2024
- Dividend Yield
- CYTK N/A
- AXS 2.06%
- EPS Growth
- CYTK N/A
- AXS 15.01
- EPS
- CYTK N/A
- AXS 7.19
- Revenue
- CYTK $3,219,000.00
- AXS $5,967,185,000.00
- Revenue This Year
- CYTK N/A
- AXS N/A
- Revenue Next Year
- CYTK $911.39
- AXS $9.18
- P/E Ratio
- CYTK N/A
- AXS $12.04
- Revenue Growth
- CYTK N/A
- AXS 6.37
- 52 Week Low
- CYTK $30.68
- AXS $53.49
- 52 Week High
- CYTK $110.25
- AXS $86.92
- Technical
- Relative Strength Index (RSI)
- CYTK 39.67
- AXS 67.39
- Support Level
- CYTK $49.64
- AXS $84.98
- Resistance Level
- CYTK $59.39
- AXS $86.92
- Average True Range (ATR)
- CYTK 2.23
- AXS 1.27
- MACD
- CYTK -0.54
- AXS 0.39
- Stochastic Oscillator
- CYTK 4.88
- AXS 100.00
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a property and casualty insurance company that provides various products and services to clients and distribution partners. The company has operating subsidiaries and branch networks based in Bermuda, the United States, Canada, Europe, and Singapore. Its business consists of two distinct global underwriting platforms, AXIS Insurance, and AXIS Reinsurance. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks.